Boyalife Investment Fund I, Inc., 10% Owner at Nuo Therapeutics, Inc. (AURX), bought 3,150,000 shares at $0.22 ($693K) on 2017-09-11, disclosed to the SEC on 2017-09-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.